In the pharmaceutical industry, pricing a new product is one of the most complex decisions to be made given the number of stakeholders involved. Our client was a multi- national pharmaceutical company that recently developed a revolutionized cancer treatment but was struggling with communicating its value proposition to the market. The Pricing Solutions team developed recommendations for market access and value pricing strategy in the EU5 and USA for the client’s novel, first -in-class, ultra-orphan oncology therapy. The Challenge Our client had significant experience in developing novel therapies but was struggling with pricing their products according to value and in bringing them to market. Given the initial data from phase I trials, our client had high expectations

Join for free to read